Postes actifs de Malin Hultqvist Hopkins
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Redoxis AB
 Redoxis AB Medical SpecialtiesHealth Technology Redoxis AB focuses on preclinical drug development and validation in autoimmune diseases. The firm focuses on preclinical development of small molecules that target molecular pathways in the immunological responses associated with autoimmune diseases such as rheumatoid arthritis and multiple sclerosis. The company was founded by David Rikard Martinsson Holmdahl and Jan Peter Olofsson in 2007 and is headquartered in Gothenburg, Sweden. | Directeur/Membre du Conseil | 01/05/2016 | - |
| Directeur Général | 01/05/2016 | - |
Historique de carrière de Malin Hultqvist Hopkins
Statistiques
Internationale
| Suède | 2 |
Opérationnelle
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectorielle
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Redoxis AB
Redoxis AB Medical SpecialtiesHealth Technology Redoxis AB focuses on preclinical drug development and validation in autoimmune diseases. The firm focuses on preclinical development of small molecules that target molecular pathways in the immunological responses associated with autoimmune diseases such as rheumatoid arthritis and multiple sclerosis. The company was founded by David Rikard Martinsson Holmdahl and Jan Peter Olofsson in 2007 and is headquartered in Gothenburg, Sweden. | Health Technology |
- Bourse
- Insiders
- Malin Hultqvist Hopkins
- Expérience
